Expert Pharmacy Insights
Evidence-based health articles, medication guides, and wellness tips from certified pharmacists
Diane-35 in the USA: Why It Isn't FDA-Approved, What It Treats, Clot Risk and US Alternatives
Diane-35 combines cyproterone acetate 2 mg with ethinylestradiol 35 micrograms for acne and hirsutism in women. It is prescribed in Canada, the UK, Australia and India but has never been FDA-approved. This guide covers its licensed uses, trial results, the 2013 European review, blood clot risk against other pills, the 2020 meningioma review, who should not take it, and FDA-approved US alternatives.
Missed a Birth Control Pill: The Seven Day Rule and Why the Week Matters
Seven consecutive active tablets suppress ovulation and seven or more hormone-free days let it restart. That single number explains why one missed tablet needs nothing, two in week three means skipping the break, and two in week one may need emergency contraception.
Yaz vs Yasmin: Same Progestin, Different Estrogen Dose and a Different Pill Schedule
Yaz and Yasmin both contain drospirenone 3 mg. What differs is the ethinyl estradiol dose, 0.02 mg against 0.03 mg, the 24 plus 4 versus 21 plus 7 pack schedule, and the licensed indications in United States labelling.
Birth Control Pills and Blood Clots: What the Progestin Generation Actually Changes
United States labelling puts venous thromboembolism at roughly 3 to 9 events per 10,000 woman-years on the combined pill against 40 to 65 in the twelve weeks after delivery. Here is what the progestin generation, the estrogen dose and your own history actually change.
Showing 1-4 of 4 articles